Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs

Romford
22 May 2013 16:11



Bristol & South West
22 May 2013 15:42



Locations across UK
22 May 2013 15:38


Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Testimonials
I would like to thank Zenopa Recruitment for their time and the manner in which they dealt with my job application.
Sukhi, 2012

Inhibiting protein aids cancer treatment

9 September 2008 00:00 in Industry related health news


Researchers have said that inhibiting a protein can help prevent the growth of cancer cells and kill off tumour cells.

The study, funded by Cancer Research UK and the Institute of Cancer Research, published today claims that drugs which inhibit the HSP70 protein as well as those which block HSP90 help kill cancer cells.

New drugs which inhibit HSP70 could be developed and help with cancer treatment, the report claims.

Lead author professor Paul Workman said that the study's findings were surprising and that knocking out two particular proteins HSC70 and HSP72, forms of the HSP70 protein, caused cell death only in cancer cells.

"What?s most exciting is that not only can knocking out both HSC70 and HSP72 eliminate the dangerous cancer-causing proteins, but in addition this approach can kill cancer cells much very more effectively than normal cells," he said.

"We hope that in the future, drugs can be designed to inhibit the HSP70 proteins, following on from those that already block HSP90, to stop tumour growth and kill off cancer cells."

Professor Herbie Newell, Cancer Research UK?s executive director of clinical and translational research, added: "This is a great example of why cancer research is such an exciting field. There are constantly new discoveries being made that challenge our current ways of thinking and that open up new doors for developing better and more targeted therapies."

Other news stories from 09/09/2008

Recent news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd